Dişi Köpeklerde GnRH Agonistlerinin Reprodüktif Kullanımı

Year 2014, Volume: 11 Issue: 3, 205 - 209, 01.12.2014

Aytekin Günay

Abstract

Son yıllarda pet hayvan reprodüksiyonu alanındaki çalışmalar GnRH agonisti deslorelinin kullanımı üzerine yoğunlaşmıştır.

Deslorelin, küçük dozda yavaş salınım gösteren implant formundadır. Çalışmalar, anöstrustaki dişi köpeklerde

östrusun uyarılması, prepubertal dişilerde östrusun baskılanması ile uzun süreli kontrasepsiyon üzerine odaklanmıştır.

Fakat hala östrus siklusunun farklı evrelerindeki GnRH uygulamalarına ilişkin bilgi eksiklikleri bulunmaktadır.

Günümüzde, GnRH agonist implantları, östrus siklusunun geri dönüşümlü baskılanması yanında anöstrustaki dişi köpeklerde

fertil kızgınlıkların uyarımında dopamin agonistlerine alternatif olarak kullanım alanı bulmaktadır.

Keywords

Dişi köpek, deslorelin, GnRH agonist, reprodüksiyon

Reproductive Use of GnRH Agonists in Bitches

Abstract

In recent years, studies have focused on use of GnRH agonist desloreline in small animal reproduction.

Desloreline is in the form of an implant exhibiting slow release at low doses. Research has focused on the use of

GnRH implants for long-term contraception the induction of oestrus in anoestrus and suppression of oestrus in

prepubertal bitches. However, there is still lack of information about GnRH treatment in different stages of oestrus

cycle. Nowadays, GnRH agonist implants can be used as an alternative to dopamine agonists to induce fertile oestrus

of bitches in anoestrus as well as to suppress oestrus.

Keywords

Bitch, desloreline, GnRH agonist, reproduction

References

• 1. Adams TE. Using gonadotropin-releasing hormone (GnRH) and GnRH analogs to modulate testis function and enhance the productivity of domestic animals. Anim Reprod Sci 2005; 88 (1-2): 127-39.
• 2. Arlt SP, Spankowsk S, Heuwieser W. Follicular cysts and prolonged oestrus in a female dog after administration of a deslorelin implant. N Z Vet J 2011; 59 (29): 87-91.
• 3. Aspden WJ, Jakson A, Trigg TE, D’Occhio MJ. Pituitaryexpression of LH- and FSH-subunit mRNA, cellular distrubition of LH- subunit mRNA and LH and FSH synthesis during and after treatment with a gonadotropin releasing hormone agonist in heifers. Repro Fertil and Dev 2003; 15 (3): 149-56.
• 4. Beijerink NJ, Dieleman SJ, Kooistra HS, Okkens AC. Low doses of bromocriptine shorten the interestrous interval in the bitch without lowering plasma prolactin concentration. Theriogenology 2003; 60 (7): 1379-86.
• 5. Cirit Ü, Bacinoglu S, Cangül I T, Horoz Kaya H, Tas M, Ak. The effects of a low dose of cabergoline on induction of estrus and pregnancy rates in anestrous bitches. Anim Reprod Sci 2007; 101 (1-2): 134-44.
• 6. Corrada, Y, Hermo G, Johnson CA, Trigg TE, Gobello C. Short-term progestin treatments prevent estrous induction by a GnRH agonist implant in anestrous bitches. Theriogenology 2006; 65 (2): 366-73.
• 7. Dominique M. Behavioural changes after treatment with GnRH implants in male dogs; the behavioural effects of a reversible chemical castration. In comparison: a literature review of the behavioural effects of surgical castration in male dogs. Thesis. Department of Clinical Sciences of Companion Animals Faculty of Veterinary Medicine, Utrecht University-Holland, 2009.
• 8. Fontaine E, Mir F, Vannier F, Gérardin A, Albouy M, Navarro C, Fontbonne A. Induction of fertile oestrus in the bitch using Deslorelin, a GnRH agonist. Theriogenology 2011; 76 (8): 1561-6.
• 9. Fontaine E, Fontbonne A. Use of Deslorelin to control fertility in the bitch. In Symposium Deslorelin: Deslorelin in practice, 7th EVSSAR Congress. Louvain la Neuve. May, 15-17, 2010; Belgium.
• 10. Gobello C, Castex G, Corrada Y. Use of cabergoline to treat primary and secondary anestrus in dogs. J Am Ved Med Assoc 2002; 220 (11): 1653-4.
• 11. Gobello C. Dopamine agonists, anti-progestins, anti-androgens, long-term-release GnRH agonists and anti-estrogens in canine reproduction: A review. Theriogenology 2006; 66(6-7): 1560-7.
• 12. Gobello C. New GnRH analogs in canine reproduction. Anim Reprod Sci 2007; 100 (1-2):1-13.
• 13. Gorbman A, Sower SA. Evolution of the role of GnRH in animal (metazoan) biology. Gen Comp Endocrinol 2003; 134 (3): 207-13.
• 14. Günay A, Günay Ü, Soylu MK. Cabergoline applications in early and late anoestrous periods on German shepherd dogs. Revue Méd Vét 2004; 155 (11): 557-60.
• 15. Günay A, Soylu M K. A study of induction of oestrus and ovulation in bitches in anoestrus period. 34 Jahrestagung Physiology und Pathology der fortpflazung 24 Veterinar Humanmedizinische Gemenischaftstagung. Februar, 127, 2001; Giessen-Germany.
• 16. Günay, A, Soylu, MK. Anöstrus dönemindeki köpeklerde östrus ve ovulasyonun uyarılması üzerine çalışmalar. U Ü Vet Fak Derg 1996; 15 (1-2-3): 165-75.
• 17. Güngör Ö, Kaya M, Gürbulak K, Oral H, Kaya S, Kaçar C. Use of GnRH agonist (desloreline) in combination with PGF2α on the termination of pregnancy in bitches. Kafkas Üniv Vet Fak Derg 2010; 16 (6): 903-08.
• 18. Herbert CA, Trigg, TE: Applications of GnRH in the control and management of fertility in female animals. Anim Reprod Sci 2005; 88 (1-2): 141-53.
• 19. Junaidi A, Williamson PE, Martin GB, Stanton PG, Blackberry MA, Cummins JM, Trigg TE. Pituitary and testicular endocrine responses to exogenous gonadotrophinreleasinghormone (GnRH) and luteinising hormone in male dogs treated with GnRH agonist implants. Reprod Fertil Dev 2007; 19 (8): 891-98.
• 20. Kaya D, Aslan S, Kaya S, Kuru M, Kaçar C, Schäfer-Somi S. Clinical and endocrine short-term effects of GnRH analogue deslorelin in prepubertal bitches: Does a “flare-up” occur? Kafkas Univ Vet Fak Derg 2013; 19 (2): 299-304.
• 21. Kooistra HS, Okkens AC, Bevers MM, Popp-Snijders C, van Haaften B, Dieleman SJ, Schoemaker J. Bromocriptine-induced premature oestrus is associated with changes in the pulsatile secretion pattern of follicle-stimulating hormone in beagle bitches. J Reprod Fertil 1999; 117 (2): 387-93.
• 22. Maenhoudt C, Santos NR, Fontaine E, Mir F, Reynaud K, Navarro C, Fontbonne A. Results of GnRH agonist implants in oestrous induction and oestrous suppression in bitches and queens. Reprod Dom Anim 2012, 47 (6): 393-7.
• 23. Metallinou C, Asimakopoulos B, Schröer A, Nikolettos N. Gonadotropin-releasing hormone in the ovary. Reprod Sci 2007; 14 (8): 737-49.
• 24. Millar RP. GnRHs and GnRH receptors. Anim Reprod Sci 2005; 88 (1-2): 5-28.
• 25. Padula AM. GnRH analogues-agonists and antagonists. Animal Reprod Sci 2005; 88 (1-2): 115-26.
• 26. Palm J, Reichler IM. Effectiveness of deslorelin acetate for the suppression of heat in the bitch. EVSSAR Congress. May, 87-88, 2010; Louvain la Neuve-Belgium.
• 27. Ponglowhapan S. Clinical applications of GnRH agonist Deslorelin in dogs and cats. Thai J Vet Med Suppl 2011; 41: 59-63.
• 28. Romagnoli S, Stelletta C, Milani C, Gelli D, Falomo ME, Mollo A. Clinical use of deslorelin for the control of reproduction in the bitch. Reprod Dom Anim 2009; 44 (2) : 36-9.
• 29. Schally AV. Luteinizing hormone-releasing hormone analogs: Their impact on the control of tumorigenesis. Peptides 1999; 20 (10): 1247-62.
• 30. Sung M, Armour AF, Wright PJ. The influence of exogenous progestin on the occurrence of proestrous or estrous signs, plasma concentrations of luteinizing hormone and estradiol in deslorelin (GnRH agonist) treated anestrous bitches. Theriogenology 2006; 66 (6-7): 1513-7.
• 31. Temple JL, Millar RP, Rismann EF. An evolutionarily conserved form of gonadotropin–releasing hormone coordinates energy and reproductive behaviour. Endocrinology 2003; 144 (1): 13-9.
• 32. Toydemir TSF, Sontaş BH, Kılıçarslan MR. New indications of a GnRH agonist deslorelin in small animal reproduction. EVSSAR 15th Congress of the European Veterinary Society for Small Animal Reproduction. Proceedings of the 7th International Symposium on Canine and Feline Reproduction. July, 26-29, 2012; Whistler- Canada.
• 33. Trigg T E, Doyle AG, Walsh JD, Swangchan-uthai T. A review of advances in the use of the GnRH agonist deslorelin in control of reproduction. Theriogenology 2006; 66 (6-7): 1507-12.
• 34. Trigg TE, Wright PJ, Armour AF, Williamson PE, Junaidi A, Martin GB, Doyle AG, Walsh J. Use of a GnRH analogue implant to produce reversible long-term suppression of reproductive function in male and female domestic dogs. J Reprod Fertil Suppl 2001; 57: 255-61.
• 35. Volkmann D, Kutzler M, Wheeler R, Krekeler N. The use of deslorelin implants for the synchronization of estrous in diestrous bitches. Theriogenology 2006; 66 (6-7): 1497-501.
• 36. von Heimendahl, A, Miller C. Clinical evaluation of Deslorelin to induce oestrus, ovulation and pregnancy in the bitch. EVSSAR 15th Congress of the European Veterinary Society for Small Animal Reproduction. Proceedings of the 7th International Symposium on Canine and Feline Reproduction. July, 26-29, 2012; Whistler- Canada.
• 37. Walter B, Otzdorff C, Brugger N, Braun J. Estrus induction in Beagle bitches with the GnRH-agonist implant containing 4.7 mg Deslorelin. Theriogenology 2011; 75 (6): 1125-9.
• 38. Wright PJ, Verstegen JP, Onclin K, Jöchle W, Armour AF, Martin GB, Trigg TE. Supression of the oestrus responses of bitches to the GnRH analogue deslorelin by progestin. J Reprod Fertil Suppl 2001; 57: 263-8.
• 39. Yüksel HT, Güngör Ö. Köpeklerde istenmeyen gebeliklerin sonlandırılmasına güncel medikal yaklaşımlar. Dicle Üniv Vet Fak Derg 2012; 1 (1): 1-6.
• 40. Zöldág L, Fekete S, Csáky I, Bersényi A. Fertile estrus induced in bitches by bromocryptine, a dopamine agonist: A clinical trial. Theriogenology 2001; 55 (8): 1657-66.